#going concern
2 stories
Loss-making Nscale seeks $35 billion valuation
The AI data center company is going public despite never turning a profit and warning of bankruptcy risk.
Fortune · 1m
Can Zenas BioPharma justify its $108M quarterly burn?
A clinical-stage biotech with $673.9M in cash races toward an FDA decision that will make or break its future.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 2m